![]() |
市场调查报告书
商品编码
1465117
女性骨盆腔植入市场:按产品类型、适应症和最终用户划分 - 全球预测 2024-2030Female Pelvic Implants Market by Product Type (Vaginal Graft Implants, Vaginal Mesh Implants, Vaginal Sling), Indication (Pelvic Organ Prolapse, Stress Urinary Incontinence), End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年女性骨盆腔植入市场规模为9.7232亿美元,2024年将达10.1559亿美元,2030年将达到13.4729亿美元,复合年增长率为4.76%。
女性骨盆腔植入是一种专用设计用于治疗骨盆底疾病的医疗设备,包括骨盆器官脱垂(POP)和压力性尿失禁(SUI)。这些情况通常是由分娩、手术或老龄化引起的,并影响骨盆底的结构和强度。透过手术插入含有合成网或生物材料的植入,以支撑骨盆器官,包括膀胱、子宫和肠道,并修復或强化受损或衰弱的骨盆底肌肉和组织。随着全世界女性骨盆底疾病的增加,对骨盆腔植入的需求也增加。医疗基础设施的改善和对骨盆底疾病意识的提高正在促进女性用骨盆植入市场的成长。然而,监管挑战和过去有关网状植入安全性的诉讼极大地限制了市场的成长。此外,缺乏训练有素的外科医生来有效地进行骨盆植入手术,限制了女性可用的治疗选择,包括网状糜烂、感染和植入排斥併发症,导致患者不适和需要再次手术。然而,对更安全、更俱生物相容性的材料的持续研究可以减少併发症并改善患者的治疗结果,从而提供显着的成长机会。微创手术技术的开拓可能会提高患者的接受度并扩大骨盆腔植入市场。
主要市场统计 | |
---|---|
基准年[2023] | 97232万美元 |
预测年份 [2024] | 1,015,590,000 美元 |
预测年份 [2030] | 1,347.29 百万美元 |
复合年增长率(%) | 4.76% |
产品类型:由于有效治疗压力性尿失禁,阴道吊带的使用范围扩大
阴道移植植入是用于治疗和控制骨盆器官脱垂(POP) 和压力性尿失禁的手术装置。这些植入旨在为虚弱的骨盆底肌肉和器官提供额外的支撑。它们可以由聚丙烯之类的合成材料製成,或由自体(来自患者自己的身体)、异种(来自不同物种)或同种异体(来自相同物种)的生物材料製成。阴道移植植入的主要目的是恢復正常的骨盆底功能和解剖结构,并提高患者的生活品质。阴道网状植入是阴道植入的子集,由合成的、不可吸收的网状材料专门製成。它常用于骨盆器官脱垂和压力性尿失禁等疾病的手术治疗。这些植入旨在永久强化骨盆底薄弱的结构。阴道吊带是一种外科手术,利用一条合成网或生物材料在尿道周围形成支撑吊带。手术的具体目的是为尿道提供额外的支撑,以防止运动、咳嗽或打喷嚏时发生的不自觉尿液漏出。阴道吊带因其有效性而受到高度讚扬,并已成为患有压力性尿失禁的女性广泛接受的手术选择。
最终用户:拥有完善设施和广泛专家的医院越来越多地采用女性骨盆植入。
门诊手术中心 (ASC) 是现代化的医疗机构,提供当天的手术护理,包括诊断和预防解决方案及程序。 ASC 以其效率和成本效益而闻名。 ASC 为进行小型手术(包括女性骨盆腔植入)提供了便利且安全的环境。医院是使用女性骨盆腔植入的主要场所。医院拥有更全面的基础设施和更广泛的专家,可以处理骨盆器官脱垂和失禁的复杂病例。医院配备了先进的医疗解决方案和医疗设备,以及出色的术后护理,使其成为包括骨盆植入在内的复杂手术干预的最合适环境。我们的多学科团队和加护病房进一步支持了我们在骨盆腔植入应用方面的主导地位。专科诊所专注于特定的医学领域或特定的服务,例如治疗骨盆底疾病的泌尿生殖医学。这些诊所提供有针对性的治疗,并经常聘请在女性骨盆健康方面拥有深厚专业知识的专家。儘管专科诊所在需要骨盆腔植入的疾病的诊断和初步管理中发挥重要作用,但它们在实际植入手术中的作用可能会受到设施手术能力的限制。
区域洞察
由于人口老化、强大且高度发达的医疗基础设施以及人们对骨盆健康问题的认识不断提高,美洲,特别是美国和加拿大对女性骨盆植入的需求很高。美国的研究活动非常活跃,由学术机构和工业界共同主导。美洲最近的专利展示了植入材料和微创应用技术的创新。包括中国、日本、印度等在内的亚太地区女性用骨盆腔植入市场正在快速成长。这一增长的推动因素包括医疗费用的上涨、对骨盆疾病的认识提高以及医疗基础设施的改善。日本以其先进的研究和高技术采用率而脱颖而出。中国和印度由于人口众多且获得医疗服务的机会不断增加,正在成为重要的市场。该地区对当地製造和研究项目进行了大量投资。欧盟国家受益于先进的医疗保健系统和对骨盆健康问题的广泛认识,促进了创新骨盆植入的开发。欧盟的研究和发展得到大学、医院和公司之间的津贴和合作的支持。管理医疗产品製造和性能的多项严格法规的存在,为女性骨盆植入的发展创建了高度标准化的框架。
FPNV定位矩阵
FPNV定位矩阵对于评估女性骨盆腔植入市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对女性骨盆植入市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.女性骨盆腔植入市场规模及预测为何?
2.女性骨盆植入市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?
3.女性骨盆腔植入市场的技术趋势和法规结构是什么?
4.女性骨盆腔植入市场主要厂商的市场占有率为何?
5.进入女性骨盆腔植入市场的合适形式和策略手段是什么?
[197 Pages Report] The Female Pelvic Implants Market size was estimated at USD 972.32 million in 2023 and expected to reach USD 1,015.59 million in 2024, at a CAGR 4.76% to reach USD 1,347.29 million by 2030.
Female pelvic implants are medical devices designed specifically for the treatment of pelvic floor disorders, including pelvic organ prolapse (POP) and stress urinary incontinence (SUI). These conditions are often caused by childbirth, surgery, or aging, affecting the pelvic floor's structure and strength. The implants, which include synthetic mesh or biological materials, are surgically inserted to support the pelvic organs, including the bladder, uterus, and bowel, and to repair or reinforce the damaged or weakened pelvic floor muscles and tissues. The rising cases of pelvic floor disorders among women globally create a need for pelvic implants. Improved healthcare infrastructure and heightened awareness about pelvic floor disorders have contributed to the growth of the female pelvic implant market. However, regulatory challenges and historical lawsuits related to safety concerns of mesh implants pose considerable restraints on market growth. Moreover, the shortage of adequately trained surgeons to perform pelvic implant surgeries effectively limits the treatment options available to women, and complications such as mesh erosion, infection, and implant rejection have been reported, leading to patient discomfort and the need for revision surgeries. However, continued research into safer, more biocompatible materials can reduce complications and improve patient outcomes, presenting significant growth opportunities. The development of less invasive surgical techniques would likely increase patient acceptance and widen the market for pelvic implants.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 972.32 million |
Estimated Year [2024] | USD 1,015.59 million |
Forecast Year [2030] | USD 1,347.29 million |
CAGR (%) | 4.76% |
Product Type: Expanding usage of vaginal sling due to its efficacy in treating stress urinary incontinence
Vaginal graft implants are surgical devices used in the treatment and management of pelvic organ prolapse (POP) and stress urinary incontinence. These implants are designed to provide additional support to the weakened pelvic floor muscles and organs. They can be made from synthetic materials, such as polypropylene, or biological materials, which can be either autologous (from the patient's own body), heterologous (from a different species), or allogeneic (from the same species). The primary goal of vaginal graft implants is to restore normal pelvic floor function and anatomy, thereby improving the patient's quality of life. Vaginal mesh implants are a subset of vaginal graft implants specifically constructed from synthetic, non-absorbable mesh. They are commonly used for the surgical treatment of conditions, including pelvic organ prolapse and stress urinary incontinence. These implants are designed to provide a permanent reinforcement to the weakened structures of the pelvic floor. The vaginal sling is a surgical procedure that utilizes a strip of synthetic mesh or biological material to create a supportive sling around the urethra. This procedure is specifically aimed at preventing involuntary urine leakage that occurs during physical activities, coughing, or sneezing by providing additional support to the urethra. Vaginal slings are highly regarded for their efficacy and have become a widely accepted surgical option for women suffering from stress urinary incontinence.
End User: Emerging adoption of female pelvic implants by hospitals owing to their comprehensive facilities and wide range of specialists
Ambulatory surgical centers (ASCs) are modern healthcare structures that provide same-day surgical care, including diagnostic and preventive solutions and procedures. ASCs are known for their efficiency and cost-effectiveness. They offer a convenient and safe environment for the performance of minor surgeries, including those involving female pelvic implants. Hospitals are the primary setting for the use of female pelvic implants. They have a more comprehensive infrastructure and a broader range of specialists to manage complex cases of pelvic organ prolapse and incontinence. Hospitals are equipped with advanced medical solutions and equipment and offer extensive postoperative care, making them the most suitable environment for complex surgical interventions involving pelvic implants. The availability of multi-disciplinary teams and intensive care units further supports their leading position in the application of these implants. Specialty clinics focus on particular fields of medicine or specific services, including urogynecology, which involves the treatment of pelvic floor disorders. These clinics provide targeted care and often employ specialists with deep expertise in female pelvic health. While specialty clinics play a crucial role in the diagnosis and initial management of conditions necessitating pelvic implants, their role in the actual implantation procedures may be limited by the surgical capacity of the facility.
Regional Insights
In the Americas, particularly in the United States and Canada, there is a high need for female pelvic implants due to aging populations, robust and highly developed healthcare infrastructure, and increasing awareness of pelvic health issues. The U.S. exhibits robust research activities led by both academic institutions and industry players. Recent patents in the Americas region demonstrate innovations in implant materials and minimally invasive application techniques. The Asia Pacific region, including China, Japan, India, and other countries, is witnessing rapid growth in the female pelvic implant market. This growth is spurred by increasing healthcare expenditures, rising awareness of pelvic disorders, and improving healthcare infrastructure. Japan stands out for its advanced research and a high rate of technology adoption. China and India are emerging as significant markets due to their large populations and increasing access to healthcare services. Investments in local manufacturing and research initiatives are prominent in this region. European Union countries benefit from advanced healthcare systems and widespread awareness of pelvic health issues, driving the development of innovative pelvic implants. Research and development in the EU are supported by grants and collaborations among universities, hospitals, and companies. The presence of several stringent regulations governing the manufacture and performance of medical products creates a highly standardized framework for the progress of female pelvic implants.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Female Pelvic Implants Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Female Pelvic Implants Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Female Pelvic Implants Market, highlighting leading vendors and their innovative profiles. These include Advin Urology, B. Braun of America Inc., Betatech Medical, Boston Scientific Corporation, Caldera Medical, CARDIOLINK S.L. by CB Scientific, Inc., Coloplast Corp., Cook Group Incorporated, CurvaFix, Inc., Medtronic, Narang Medical Limited, Neomedic Int, Olympus Corporation, PALEX MEDICAL, S.A, pfm Medical GmbH, PROMEDON GmbH, SARS Cousin Biotech, Tecomet, Inc., Zimmer Biomet, and ZSI Surgical Implants S.R.L..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Female Pelvic Implants Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Female Pelvic Implants Market?
3. What are the technology trends and regulatory frameworks in the Female Pelvic Implants Market?
4. What is the market share of the leading vendors in the Female Pelvic Implants Market?
5. Which modes and strategic moves are suitable for entering the Female Pelvic Implants Market?